Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings

BACKGROUND: As use of dolutegravir (DTG) becomes more common in resource limited settings (RLS), the demand for integrase resistance testing is increasing. Affordable methods for genotyping all relevant HIV-1 pol genes (i.e., protease (PR), reverse transcriptase (RT) and integrase (IN)) are required...

Descripción completa

Detalles Bibliográficos
Autores principales: Manyana, Sontaga, Pillay, Melendhran, Gounder, Lilishia, Khan, Aabida, Moodley, Pravi, Naidoo, Kogieleum, Chimukangara, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912687/
https://www.ncbi.nlm.nih.gov/pubmed/36759801
http://dx.doi.org/10.1186/s12981-023-00505-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912687/
https://www.ncbi.nlm.nih.gov/pubmed/36759801
http://dx.doi.org/10.1186/s12981-023-00505-3

Ejemplares similares